Form 4: Doximity Director Sells DOCS Shares via 10b5-1 Plan

Doximity Director Regina M. Benjamin sold 5,000 shares of Class A Common Stock for $70.84 per share on October 10, 2025, following the exercise of stock options and conversion of Class B shares, as part of a pre-arranged trading plan.

Summary

• Regina M. Benjamin, a Director of Doximity, Inc. (DOCS), engaged in transactions involving the company's securities on October 10, 2025.
• The transactions included the exercise of a stock option to acquire 5,000 shares of Class B Common Stock at an exercise price of $2.21 per share.
• Immediately following the option exercise, these 5,000 shares of Class B Common Stock were converted into 5,000 shares of Class A Common Stock.
• Subsequently, 5,000 shares of Class A Common Stock were sold at a price of $70.84 per share.
• These sales were executed automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 26, 2025.
• Following these transactions, the Reporting Person beneficially owns 19,839 shares of Class A Common Stock directly and 351,138 stock options (right to buy Class B Common Stock).

Sentiment

Score: 5

Explanation: The sentiment is neutral. While insider selling can sometimes be perceived negatively, the fact that it was conducted under a pre-arranged Rule 10b5-1 plan mitigates concerns, as it reflects personal financial planning rather than a reaction to new company developments.

Positives

• The exercise of stock options indicates the director is realizing value from their compensation, which can be a positive signal of perceived value.
• The transactions were conducted under a Rule 10b5-1 trading plan, indicating pre-planned sales for personal financial management rather than a reaction to new, negative company-specific information.

Negatives

• The sale of 5,000 shares by a director, even if pre-planned, represents a reduction in insider ownership, which can sometimes be viewed with caution by investors.

Corporate Governance

Stakeholder Impact

• Shareholders: The sale of shares by a director could be interpreted in various ways, from routine personal financial management to a signal about future company performance, potentially influencing investor sentiment.

Key Dates

Recommendation

The Form 4 filing details a pre-scheduled insider sale under a Rule 10b5-1 plan, which is a routine liquidity event for executives and directors. It does not provide new fundamental information about Doximity's operational performance or strategic direction that would warrant a change in investment recommendation based solely on this filing. Investors should consider this transaction in the broader context of the company's financial results and market conditions.

Keywords

Doximity, DOCS, Insider Trading, Form 4, Stock Sale, 10b5-1 Plan, Director, Stock Options, Class A Common Stock, Class B Common Stock